Understanding Parkinson’s

There is a lot to know about Parkinson's disease. Learn about symptoms, how it is diagnosed and what treatment options are available.
Living with Parkinson’s

While living with PD can be challenging, there are many things you can do to maintain and improve your quality of life and live well with Parkinson's disease.
Resources & Support

Living well with Parkinson’s disease (PD) means getting the support you need — from tools that help you work alongside your care team to resources that empower you.
Advancing Research

Our research has led to breakthroughs in treatment and improved care that bring hope to the entire Parkinson's community.
How You Can Help

There are many ways you can support the fight against Parkinson’s. Whatever form your gift takes, you can be confident that it goes toward providing crucial resources for those affected by this disease.

Podcasts

Episode 26: Medical Marijuana: Going Green for PD?

More and more people are exploring medical marijuana, also called cannabis, as a treatment option for various chronic health conditions, including Parkinson’s disease. Several states have legalized medical cannabis, but because federal drug laws have prevented scientific investigations on cannabis and its components for many years, much is still unknown about its use for medical purposes. Patients have questions about it, and physicians are still feeling their way through the landscape of medicinal cannabis use. Dr. Danny Bega of Northwestern University’s Parkinson’s Disease and Movement Disorders Center in Chicago, a Parkinson’s Foundation Center of Excellence, sheds light on some of the issues and concerns surrounding the use of medicinal cannabis.

Released: April 10, 2018

Dr. Bega is a fellowship trained, board-certified, movement disorders neurologist at the Northwestern University Feinberg School of Medicine. He has completed clinical training in neurology at Harvard’s Massachusetts General Hospital and Brigham & Women’s Hospital. Dr. Bega has expertise in the care and management of patients with a variety of movement disorders including Parkinson’s disease, and is the director of the Northwestern Huntington’s disease and Wilson’s disease clinics. He has completed master’s level training in clinical investigations through the Northwestern Graduate School and is involved in several industry sponsored trials. His primary area of interest is the study of alternative and non-pharmacologic interventions in movement disorders and their impact on quality of life.

Want more?

Don't forget to subscribe! There are many ways to listen: Apple Podcasts, Google Play, TuneIn (Amazon Echo), Spotify or RSS Feed. (Need help subscribing? See our quick guide.)

For all of our Substantial Matters podcast episodes, visit Parkinson.org/Podcast.

About Danny Bega, MD, MSCI

Want more?

Expert Briefing: Marijuana: What Do We Really Know?

Managing PD Mid-Stride: A Treatment Guide to Parkinson's Disease

Surgical Options: A Treatment Guide to Parkinson's Disease